• Passa al contenuto principale
BC

biochimica clinica

it_IT Italian
it_IT Italian en_US English
  • Home
  • Casi clinici
  • Ahead of print e Ultimo Fascicolo - Accedi per visualizzare gli articoli
  • Archivio BC fino a 2024
  • Sottometti un articolo
  • Norme Autori
  • Cerca

CASI CLINICI – Case Reports

Volume:

Biochimica Clinica 2016; 40(1) e1-e3

Pubblicato on-line:

DOI:

Scarica in PDF:

Sindrome POEMS: “Hevylite” e “Freelite” a confronto

AUTORI

Mara Seguso1, Kozeta Proko1, Daniela Ciubotaru1, Sara Altinier1, Mariacristina Varagnolo1, Martina Zaninotto1, F. Adami2, Mario Plebani1
1Dipartimento di Medicina di Laboratorio, Azienda Ospedaliera - Università di Padova
2Dipartimento di Medicina, Unità di Ematologia, Università di Padova

ABSTRACT

POEMS syndrome: Heavy Light Chains vs Free Light Chains measurements

POEMS syndrome is a rare paraneoplastic, multisystemic, plasma cell discrasia characterized by Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal gammopathy and Skin changes. Most patients have high serum free light chains (sFLC) concentrations but a normal sFLC ratio. Hevylite (HLC) is a new method that allows separated quantification of the serum k and l bounded levels of the six isotype specific immunoglobulins. In this study HLC and sFLC were measured in serum samples during the follow up of two patients with POEMS syndrome. The HLC ratio of the involved monoclonal immunoglobulin could provide additional information to assess residual disease, allowing detection of relapse earlier than clinical symptoms in patients with POEMS syndrome.

BIBLIOGRAFIA

HOME
PRIVACY POLICY
5x1000 Docemus

LOGO SIBioC

EDITORE RESPONSABILE
Alberto Oliaro

EDITORIAL SECRETARY
Edizioni Minerva Medica S.p.A.
Corso Bramante 83-85, 10126 Torino
T +39 011 678282
journals.dept@minervamedica.it

Designed by Biomedia srl
© 2025 SIBioC
P. IVA IT 06484860967